Home Biosimilar Antibodies Others Others antibody Bivatuzumab (Anti-CD44v6) For research use only.
Not for use in humans.

Bivatuzumab (Anti-CD44v6)

Synonyms: BIWA 4; Anti-CD44 Recombinant Antibody

Bivatuzumab (Anti-CD44v6) is a humanized monoclonal antibody targeting against CD44v6 that could acts as a sarcoma target for CAR-redirected CIK cells. MW:145.5 KD.

Bivatuzumab (Anti-CD44v6)

Purity & Quality Control

Batch: A255501 Purity: 99% Protein concentration: 10.39mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Bivatuzumab (Anti-CD44v6) is a humanized monoclonal antibody targeting against CD44v6 that could acts as a sarcoma target for CAR-redirected CIK cells. MW:145.5 KD.

Product Details

CAS No. 214559-60-1
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Bivatuzumab (Anti-CD44v6) | Bivatuzumab (Anti-CD44v6) supplier | purchase Bivatuzumab (Anti-CD44v6) | Bivatuzumab (Anti-CD44v6) cost | Bivatuzumab (Anti-CD44v6) manufacturer | order Bivatuzumab (Anti-CD44v6) | Bivatuzumab (Anti-CD44v6) distributor